Genentech, Innovative Cancer Drug Maker, Receives $43.7B Offer From Roche Holding
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent of the biotechnology compan...
New York Times | David Jolly | Posted 07.29.2008 | Business